Medication info
Metopole Tablets (Metformin Hydrochloride)

Metopole Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
(Ildong Pharmaceutical Co., Ltd.)
Appearance
White, round film-coated tablet
Packaging
100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 199300459 · Notified 1993.10.13 · Insurance code 642900510

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on the drug's efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, treatment with this drug must be initiated at a low dose. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When the dose is up to 2000mg, it is usually divided into 2 daily doses, taken in the morning and evening. If the dose exceeds 2000mg, divide it into 3 daily doses taken with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the response to treatment with this drug and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose had been controlled with diet alone, short-term administration of this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this drug should be discontinued immediately.
Child dose
Children aged 10 years or older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may be improved by gradually increasing the dose. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
(Ildong Pharmaceutical Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to effectively manage blood sugar levels in patients with type 2 diabetes, particularly those who are overweight, when diet and exercise alone are not sufficient. It can be taken alone or in combination with other oral hypoglycemic agents or insulin, expanding treatment options. Additionally, it can be used in children aged 10 years and older and adolescents, either as monotherapy or in combination with insulin, providing safe blood sugar management across various age groups. This medication significantly contributes to the treatment of diabetes by improving blood sugar control.

How to take

Adult dose

The dose should be determined individually based on the drug's efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, treatment with this drug must be initiated at a low dose. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When the dose is up to 2000mg, it is usually divided into 2 daily doses, taken in the morning and evening. If the dose exceeds 2000mg, divide it into 3 daily doses taken with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the response to treatment with this drug and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose had been controlled with diet alone, short-term administration of this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this drug should be discontinued immediately.

Child dose

Children aged 10 years or older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may be improved by gradually increasing the dose. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it must be used with caution. It should not be administered to patients with moderate to severe renal impairment, dehydration, severe infections, heart failure, or acute myocardial infarction. The medication should be temporarily discontinued before any tests involving iodine contrast agents and can be resumed after kidney function returns to normal. This medication is contraindicated in patients with hypersensitivity to this drug or a history of type 1 diabetes or metabolic acidosis. If oral intake is difficult due to severe infections, trauma, or surgery, administration should be temporarily halted, and it can be resumed once the patient's condition improves. Patients with hepatic dysfunction or severe pulmonary function impairment should also avoid this medication. During pregnancy, it is not recommended in cases of placental insufficiency or preeclampsia risk and fetal growth should be closely monitored. Regular assessments of kidney function are necessary to prevent drug accumulation during treatment. Irregular meals, vigorous exercise, and concomitant use of other medications may increase the risk of lactic acidosis or hypoglycemia, so caution is advised. Alcohol may affect the lactate metabolism of this medication, and excessive drinking should be avoided. Symptoms such as gastrointestinal disturbances, metallic taste, skin rash, blood disorders, and liver function abnormalities may occur, and if severe, prompt medical consultation is required. In particular, if symptoms of lactic acidosis such as fatigue, muscle pain, difficulty breathing, or abdominal pain occur, medication should be immediately discontinued, and medical attention should be sought. Elderly patients or those in poor nutritional status are at higher risk for hypoglycemia, so caution is required during administration. The use of this medication in conjunction with other hypoglycemic agents may increase the risk of hypoglycemia, so blood sugar levels should be closely monitored. Pregnant or breastfeeding patients should discuss the administration of this medication with a healthcare provider, and the use during breastfeeding is not recommended. In cases of overdose, blood dialysis may be possible for drug removal, but immediate medical treatment is necessary. This medication is also available for use in children and adolescents, but their growth and development should be monitored periodically. Finally, this medication should be stored out of reach of children and not transferred to other containers.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, it is recommended to store it at room temperature between 1°C and 30°C. Proper storage helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.